Abstract
BackgroundArtemisinin-based combination therapies (ACTs) constitute the worldwide recommended antimalarial drug as first-line treatment of uncomplicated malaria. However, the safety of repeated administration of a given ACT is poorly documented. The...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have